192 related articles for article (PubMed ID: 6469997)
1. Cysteine in the triple-helical domain of one allelic product of the alpha 1(I) gene of type I collagen produces a lethal form of osteogenesis imperfecta.
Steinmann B; Rao VH; Vogel A; Bruckner P; Gitzelmann R; Byers PH
J Biol Chem; 1984 Sep; 259(17):11129-38. PubMed ID: 6469997
[TBL] [Abstract][Full Text] [Related]
2. The molecular defect in an autosomal dominant form of osteogenesis imperfecta. Synthesis of type I procollagen containing cysteine in the triple-helical domain of pro-alpha 1(I) chains.
de Vries WN; de Wet WJ
J Biol Chem; 1986 Jul; 261(19):9056-64. PubMed ID: 3722186
[TBL] [Abstract][Full Text] [Related]
3. Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
Tenni R; Cetta G; Dyne K; Rossi A; Quacci D; Lenzi L; Castellani AA
Hum Genet; 1988 Jul; 79(3):245-50. PubMed ID: 3402997
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
[TBL] [Abstract][Full Text] [Related]
5. A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain.
Valli M; Mottes M; Tenni R; Sangalli A; Gomez Lira M; Rossi A; Antoniazzi F; Cetta G; Pignatti PF
J Biol Chem; 1991 Jan; 266(3):1872-8. PubMed ID: 1988452
[TBL] [Abstract][Full Text] [Related]
6. Clinical variability of osteogenesis imperfecta reflecting molecular heterogeneity: cysteine substitutions in the alpha 1(I) collagen chain producing lethal and mild forms.
Steinmann B; Nicholls A; Pope FM
J Biol Chem; 1986 Jul; 261(19):8958-64. PubMed ID: 3722184
[TBL] [Abstract][Full Text] [Related]
7. Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta.
Raghunath M; Bruckner P; Steinmann B
J Mol Biol; 1994 Feb; 236(3):940-9. PubMed ID: 8114103
[TBL] [Abstract][Full Text] [Related]
8. Substitution of cysteine for glycine within the carboxyl-terminal telopeptide of the alpha 1 chain of type I collagen produces mild osteogenesis imperfecta.
Cohn DH; Apone S; Eyre DR; Starman BJ; Andreassen P; Charbonneau H; Nicholls AC; Pope FM; Byers PH
J Biol Chem; 1988 Oct; 263(29):14605-7. PubMed ID: 3170557
[TBL] [Abstract][Full Text] [Related]
9. Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.
Starman BJ; Eyre D; Charbonneau H; Harrylock M; Weis MA; Weiss L; Graham JM; Byers PH
J Clin Invest; 1989 Oct; 84(4):1206-14. PubMed ID: 2794057
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly.
Lamandé SR; Chessler SD; Golub SB; Byers PH; Chan D; Cole WG; Sillence DO; Bateman JF
J Biol Chem; 1995 Apr; 270(15):8642-9. PubMed ID: 7721766
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation causes a perinatal lethal form of osteogenesis imperfecta. An insertion in one alpha 1(I) collagen allele (COL1A1).
Byers PH; Starman BJ; Cohn DH; Horwitz AL
J Biol Chem; 1988 Jun; 263(16):7855-61. PubMed ID: 3372508
[TBL] [Abstract][Full Text] [Related]
12. Substitution of cysteine for glycine-alpha 1-691 in the pro alpha 1(I) chain of type I procollagen in a proband with lethal osteogenesis imperfecta destabilizes the triple helix at a site C-terminal to the substitution.
Steinmann B; Westerhausen A; Constantinou CD; Superti-Furga A; Prockop DJ
Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):747-52. PubMed ID: 1953667
[TBL] [Abstract][Full Text] [Related]
13. Type I procollagens containing substitutions of aspartate, arginine, and cysteine for glycine in the pro alpha 1 (I) chain are cleaved slowly by N-proteinase, but only the cysteine substitution introduces a kink in the molecule.
Lightfoot SJ; Holmes DF; Brass A; Grant ME; Byers PH; Kadler KE
J Biol Chem; 1992 Dec; 267(35):25521-8. PubMed ID: 1460046
[TBL] [Abstract][Full Text] [Related]
14. Heterozygosity for a large deletion in the alpha 2(I) collagen gene has a dramatic effect on type I collagen secretion and produces perinatal lethal osteogenesis imperfecta.
Willing MC; Cohn DH; Starman B; Holbrook KA; Greenberg CR; Byers PH
J Biol Chem; 1988 Jun; 263(17):8398-404. PubMed ID: 3372533
[TBL] [Abstract][Full Text] [Related]
15. Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.
Wenstrup RJ; Hunter AG; Byers PH
Hum Genet; 1986 Sep; 74(1):47-53. PubMed ID: 3759085
[TBL] [Abstract][Full Text] [Related]
16. Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta.
Bonadio J; Holbrook KA; Gelinas RE; Jacob J; Byers PH
J Biol Chem; 1985 Feb; 260(3):1734-42. PubMed ID: 2981871
[TBL] [Abstract][Full Text] [Related]
17. Substitution of arginine for glycine at position 847 in the triple-helical domain of the alpha 1 (I) chain of type I collagen produces lethal osteogenesis imperfecta. Molecules that contain one or two abnormal chains differ in stability and secretion.
Wallis GA; Starman BJ; Schwartz MF; Byers PH
J Biol Chem; 1990 Oct; 265(30):18628-33. PubMed ID: 2211725
[TBL] [Abstract][Full Text] [Related]
18. Substitution of serine for alpha 1(I)-glycine 844 in a severe variant of osteogenesis imperfecta minimally destabilizes the triple helix of type I procollagen. The effects of glycine substitutions on thermal stability are either position of amino acid specific.
Pack M; Constantinou CD; Kalia K; Nielsen KB; Prockop DJ
J Biol Chem; 1989 Nov; 264(33):19694-9. PubMed ID: 2511192
[TBL] [Abstract][Full Text] [Related]
19. Substitution of an aspartic acid for glycine 700 in the alpha 2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone.
Cohen-Solal L; Zylberberg L; Sangalli A; Gomez Lira M; Mottes M
J Biol Chem; 1994 May; 269(20):14751-8. PubMed ID: 8182080
[TBL] [Abstract][Full Text] [Related]
20. A point mutation in a type I procollagen gene converts glycine 748 of the alpha 1 chain to cysteine and destabilizes the triple helix in a lethal variant of osteogenesis imperfecta.
Vogel BE; Minor RR; Freund M; Prockop DJ
J Biol Chem; 1987 Oct; 262(30):14737-44. PubMed ID: 3667599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
